Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV-008 extension follow-up study in Finland
2008-008124-33Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of human papillomavirus bivalent vaccine in human papillomavirus infection and Cervical Cancer (CC), sponsored by GSK. Primary endpoint: Presence of oncogenic HPV DNA in cervical samples. Started Jun 2009; status: completed.
02
Drugs
human papillomavirus bivalent vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on 2008-008124-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008124-33.